These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5762370)

  • 1. Evaluation of a new concentrate for the treatment of factor IX deficiency.
    Gilchrist GS; Ekert H; Shanbrom E; Hammond D
    N Engl J Med; 1969 Feb; 280(6):291-5. PubMed ID: 5762370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hemophilia].
    Straub PW
    Dtsch Med Wochenschr; 1969 Sep; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of severe haemophilia B with a factor IX concentrate (author's transl)].
    Ludwig E; Lechner K
    Dtsch Med Wochenschr; 1974 Jun; 99(25):1355-61. PubMed ID: 4836072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive treatment of B type hemophilia: comparative evaluation between plasma and a concentrate of factor IX].
    Tribalto M; De Rossi G; Criscuolo D; Roseo I; Guarino S
    Clin Ter; 1975 Aug; 74(3):259-63. PubMed ID: 1227746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)].
    Girolami A; Cella G; Patrassi G
    Haematologica; 1974 Mar; 59(1):91-108. PubMed ID: 4212668
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgical operation in hemophilia B. Use of factor IX concentrate.
    Kasper CK
    Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a cooperative programme of profilactic treatment for haemophilia A and B (author's transl)].
    Sangre (Barc); 1978; 23(5B):780-92. PubMed ID: 725718
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary infarct in a child with hemophilia B (Christmas disease) after transfusion of large amounts of antihemophilic plasma].
    Mastalska A; Judkiewicz L; Janiszewska-Fronczak M; Gołebiowska M
    Wiad Lek; 1980 May; 33(9):735-8. PubMed ID: 7405242
    [No Abstract]   [Full Text] [Related]  

  • 10. Serologic evidence of hepatitis B virus infection in patients with hemophilia B. a multicenter study.
    Hoofnagle JH; Aronnon D; Roberts H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):606-9. PubMed ID: 1154315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
    Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
    Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated intravascular coagulation after factor IX complex resolved using purified factor IX concentrate.
    Hadley T; Djulbegovic B
    Ann Intern Med; 1991 Oct; 115(8):621-2. PubMed ID: 1892334
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum transfusion in hemophiliacs.
    Kimura A
    Tohoku J Exp Med; 1973 Oct; 111(2):125-36. PubMed ID: 4784393
    [No Abstract]   [Full Text] [Related]  

  • 15. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities of self-treatment in hemophilias. Preliminary report].
    Göbel U; Schulz RD
    Dtsch Med Wochenschr; 1972 Sep; 97(37):1376-9. PubMed ID: 5055724
    [No Abstract]   [Full Text] [Related]  

  • 20. A new drug form of blood coagulation factor IX: red blood cell-entrapped factor IX.
    Sinauridze EI; Vuimo TA; Kulikova EV; Shmyrev II; Ataullakhanov FI
    Med Sci Monit; 2010 Oct; 16(10):PI19-26. PubMed ID: 20885362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.